taurine has been researched along with Lupus Erythematosus, Systemic in 8 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine was higher in the serum from SLE patients compared to healthy controls (P < 0." | 1.56 | Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells. ( Ding, H; Fu, Q; Guo, Q; Li, G; Li, J; Meng, Y; Shen, N; Ye, Z; Yin, Z; Zhou, H, 2020) |
| "Systemic autoimmune diseases are generally treated with immunosuppressive agents." | 1.27 | Immunomodulation in autoimmune diseases. ( Fehér, J; Gergely, P; Gonzalez-Cabello, R; Láng, I, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Ding, H | 1 |
| Meng, Y | 1 |
| Li, G | 1 |
| Fu, Q | 1 |
| Guo, Q | 1 |
| Yin, Z | 1 |
| Ye, Z | 1 |
| Zhou, H | 1 |
| Shen, N | 1 |
| Gambino, CM | 1 |
| Di Bona, D | 1 |
| Aiello, A | 1 |
| Carru, C | 1 |
| Duro, G | 1 |
| Guggino, G | 1 |
| Ferrante, A | 1 |
| Zinellu, A | 1 |
| Caruso, C | 1 |
| Candore, G | 1 |
| Accardi, G | 1 |
| Hsu, TC | 2 |
| Chiang, SY | 1 |
| Wu, JH | 2 |
| Tsai, CC | 1 |
| Huang, CY | 2 |
| Chen, YC | 1 |
| Tzang, BS | 2 |
| Kuo, WW | 1 |
| Wu, SP | 1 |
| Lin, YM | 1 |
| Yen, CY | 1 |
| Romick-Rosendale, LE | 1 |
| Brunner, HI | 1 |
| Bennett, MR | 1 |
| Mina, R | 1 |
| Nelson, S | 1 |
| Petri, M | 1 |
| Kiani, A | 1 |
| Devarajan, P | 1 |
| Kennedy, MA | 1 |
| VOLKOV, VP | 1 |
| Gergely, P | 2 |
| Láng, I | 1 |
| Gonzalez-Cabello, R | 1 |
| Fehér, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proteomics Combined With Metabolomics Studies on the Efficacy of Telitacicept in Chinese Patients of Systemic Lupus Erythematosus[NCT05666336] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for taurine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells.
Topics: Animals; Dendritic Cells; Disease Progression; Female; Humans; Interferon Regulatory Factor-7; Lupus | 2020 |
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus.
Topics: Adult; Case-Control Studies; Disease Progression; Female; Genetic Association Studies; HLA-C Antigen | 2018 |
Treatment with taurine attenuates hepatic apoptosis in NZB/W F1 mice fed with a high-cholesterol diet.
Topics: Animals; Apoptosis; Cholesterol, Dietary; Female; Hepatocytes; Humans; Liver; Lupus Erythematosus, S | 2008 |
Beneficial effects of taurine on cardiac abnormality in NZB/W F1 mice fed with a high-cholesterol diet.
Topics: Animals; Apoptosis; Cholesterol, Dietary; Diet; Female; Heart Diseases; In Situ Nick-End Labeling; L | 2009 |
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Topics: Citric Acid; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Glomerulone | 2011 |
[FREE AMINO ACIDS IN THE BLOOD AND URINE OF PATIENTS WITH SOME FORMS OF DERMATOSIS].
Topics: Alanine; Amino Acids; Arginine; Aspartic Acid; Blood; Cystine; Dermatitis; Eczema; Erythema Multifor | 1964 |
Treatment of autoimmune patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Antineopl | 1991 |
Immunomodulation in autoimmune diseases.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Drug Evaluation; Glutamine; Guanylthiourea; Humans; Imm | 1986 |